Anti-GP63 antibodies were used to pre-treat MTs cultivated with myoblasts, and the results showed a reduction in infection, indicating GP63s’ involvement in host cell recognition through a yet unknown mechanism [122]. The gene discussed is LMLN; the disease is infection.